DV
Dividend Vision

KZIA — Kazia Therapeutics Ltd ADR

Kazia Therapeutics Ltd ADR (KZIA)

Its deepest 1-year drawdown was 68.2%.

Kazia Therapeutics Ltd ADR is a single-stock equity security representing American Depositary Receipts of an Australian biopharmaceutical company. The security does not currently pay distributions, making it unsuitable for income-focused strategies. This holding appeals primarily to growth-oriented investors seeking exposure to the therapeutic development sector rather than dividend investors.

KZIA key facts

Asset type
Stock
Asset class
Equity
Inception date
01/06/1999
Last close
$13.52
Market cap
$161,690,624
Average volume
142800.0
Last dividend
$12.4260
Payment date
07/14/2017
Beta
2.152
Payout ratio
0.0
Forward P/E
12.8205
EPS
$-7.33